Skip to content

Analysis

Votes against the group’s line

All roll calls · 25 Mar 2026 – 25 Sept 2026 · Nikola BARTŮŠEK

Which members voted against their group’s clear line, how often compared with the votes where the group had one, and did they vote with their national party when they did?

Cite
Export
Period Term202420252026Last 6 months
Custom dates

Showing Nikola BARTŮŠEK only. Show every member

Nikola BARTŮŠEK’s votes against the line, 58

Every vote in the selection where the member’s position differed from their group’s clear line, newest first.

Position: the member’s vote. Clear line: the position of at least two thirds of Group (at least 10 members voting), the group they sat in on that day.
DateVotePositionClear lineGroup
17 Sept 2026Final vote — text as a whole Strengthening global health resilience in partner countriesForAgainstECR
17 Sept 2026Final vote — text as a whole Impact of social media and the online environment on young peopleForAgainstECR
17 Sept 2026Paragraph 85 — part 2 Impact of social media and the online environment on young peopleForAgainstECR
17 Sept 2026Paragraph 85 — part 1 Impact of social media and the online environment on young peopleForAgainstECR
16 Sept 2026Final vote on the motion for a resolution Genetically modified maize MON 87460AgainstForECR
16 Sept 2026Final vote on the motion for a resolution Genetically modified soybean MON 94313AgainstForECR
16 Sept 2026Final vote on the motion for a resolution Genetically modified soybean GMB151 x DAS-44406-6AgainstForECR
16 Sept 2026Final vote — text as a whole Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Separate vote on citation 19 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Separate vote on citation 9 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Recital AC — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Recital AC — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Separate vote on recital AB Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Separate vote on recital AA Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Separate vote on recital Z Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Recital J — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsAbstainedAgainstECR
16 Sept 2026Recital J — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 63 — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 63 — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 62 — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsAbstainedAgainstECR
16 Sept 2026Paragraph 62 — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsAbstainedAgainstECR
16 Sept 2026Paragraph 48 — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsAbstainedAgainstECR
16 Sept 2026Paragraph 46 — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 45 — part 3 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 45 — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 45 — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Separate vote on paragraph 44 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 43 — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 43 — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Separate vote on paragraph 41 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 24 — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAbstainedECR
16 Sept 2026Paragraph 18 — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 16 — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAbstainedECR
16 Sept 2026Paragraph 8 — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsAbstainedAgainstECR
16 Sept 2026Paragraph 8 — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAbstainedECR
16 Sept 2026Paragraph 3 — part 2 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Paragraph 3 — part 1 Gender inequalities in health, specifically as regards gender-specific conditionsForAgainstECR
16 Sept 2026Final vote Establishing the Single Market and Customs Programme for the period 2028-2034ForAbstainedECR
15 Sept 2026Amendment 13, adding text after paragraph 40 The EU Youth Strategy 2019–2027AgainstAbstainedECR
15 Sept 2026Final vote — text as a whole Findings and recommendations of the Special Committee on the European Democracy ShieldAbstainedAgainstECR
15 Sept 2026Amendment 11, adding text after citation 70 Findings and recommendations of the Special Committee on the European Democracy ShieldAbstainedForECR
15 Sept 2026Paragraph 101 — part 1 Findings and recommendations of the Special Committee on the European Democracy ShieldForAgainstECR
15 Sept 2026Amendment 53 to paragraph 99 Findings and recommendations of the Special Committee on the European Democracy ShieldAbstainedForECR
15 Sept 2026Amendment 15, adding text after paragraph 6 Findings and recommendations of the Special Committee on the European Democracy ShieldAgainstAbstainedECR
15 Sept 2026Amendment 27 to paragraph 1 Findings and recommendations of the Special Committee on the European Democracy ShieldAgainstForECR
15 Sept 2026Final vote Market stability reserve for the EU Emissions Trading System (EU ETS): ceasing the invalidation of allowancesForAgainstECR
15 Sept 2026Amendment 94 to Article 6, paragraph 3 Establishing the Temporary Decarbonisation FundAbstainedForECR
15 Sept 2026Amendment 128 to Article 1 Carbon Border Adjustment Mechanism: extension of its scope to downstream goods and anti-circumvention measuresAbstainedForECR
15 Sept 2026Amendment 126 to Article 1 Carbon Border Adjustment Mechanism: extension of its scope to downstream goods and anti-circumvention measuresAgainstForECR
18 Jun 2026Amendment 7, adding text after paragraph 6 Continued crackdown on civic space and fundamental freedoms in Burkina FasoAgainstAbstainedECR
Show all 58 votes
Position: the member’s vote. Clear line: the position of at least two thirds of Group (at least 10 members voting), the group they sat in on that day.
DateVotePositionClear lineGroup
17 Jun 2026Final vote — text as a whole 2025 Commission report on North MacedoniaForAbstainedECR
17 Jun 2026Amendment 10, adding text after paragraph 76 2025 Commission report on North MacedoniaAbstainedForECR
17 Jun 2026Paragraph 27 — part 2 2025 Commission report on North MacedoniaForAgainstECR
17 Jun 2026Amendment 17, adding text after paragraph 46 — part 2 2025 Commission report on AlbaniaAbstainedAgainstECR
17 Jun 2026Amendment 5, adding text after paragraph 46 2025 Commission report on AlbaniaAgainstForECR
17 Jun 2026Amendment 11, adding text after paragraph 18 2025 Commission report on AlbaniaAbstainedForECR
17 Jun 2026Separate vote on paragraph 31 2025 Commission report on MontenegroForAgainstECR
17 Jun 2026Final vote — text as a whole 2025 Commission report on TürkiyeForAbstainedECR

By member, 1

Members with at least one vote where their group had a clear line. Order: by rate, for members with at least 300 clear-line votes (the rest follow by name) — not a ranking.

Against the line: votes against the group’s clear line ÷ clear-line votes (votes where the member’s group at the date had a clear line and the member voted); a count below 50. Of the votes against: opposite (for ↔ against), abstained against the line, other (for or against when the line was to abstain), and with own party — with the majority of their national party’s members in the group (at least two voting).
MemberAgainst the lineClear-line votesOppositeAbstainedOtherWith own party
Nikola BARTŮŠEK changed group , ECR · Czechia in No group for most of the period 11.8 %492361390

About these figures

What was counted, what was left out, and how.

  • 1 755 votes considered (all roll-call votes matching the filters; scope).
  • 62 of 247 decisions in the period had no final vote recorded by name (a show of hands or a count without names) and cannot be measured.
  • A vote counts against the group’s line when the group’s clear line — at least two thirds of its votes cast, with at least 10 members voting — was different from the member’s position; a divided group has no line to vote against (method). This is a different rule from group loyalty, which uses the majority line (loyalty).
  • Ordered by rate, only members with at least 300 votes where their group had a clear line are compared; fewer votes make a rate unstable, and below 50 the figure is shown as a count.
  • Each member is counted in the group they belonged to on the day of the vote (group at the date).
  • Roll calls are not a random sample: final votes on laws are recorded by name, most other roll calls because a group asked for it. A group’s line is inferred from its members’ votes; the Parliament publishes no whip.
  • Methods: Voted against the group’s clear line v1, Voted with the group’s majority line v1, Final votes and all roll calls v1, Group at the date of the vote v1.
  • Data as of 25 Sept 2026, 03:36 UTC (data stamp f37e5638cded, code 6d4005c55bde; what the stamp is).
Export
Cite

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Votes against the group’s line — All roll calls · 25 Mar 2026 – 25 Sept 2026 · Nikola BARTŮŠEK”. Analysis. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/analysis/dissent?from=2026-03-25&mep=256852&to=2026-09-25 (retrieved 25 September 2026). Data: European Parliament Open Data, https://data.europarl.europa.eu/ (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-analysis-2026-09-25,
  author = {{EU Parl Watch Research}},
  title = {{Votes against the group’s line — All roll calls · 25 Mar 2026 – 25 Sept 2026 · Nikola BARTŮŠEK}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/analysis/dissent?from=2026-03-25&mep=256852&to=2026-09-25}},
  url = {https://news.eu-parl.st-solutions.dev/analysis/dissent?from=2026-03-25&mep=256852&to=2026-09-25},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Analysis. Data: European Parliament Open Data (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}